Roche drug shows promise for less common form of MS

Discuss Ocrelizumab, a monoclonal antibody treatment for MS.

Roche drug shows promise for less common form of MS

Postby MSUK » Thu Oct 08, 2015 11:33 pm

Swiss drugmaker Roche has said its experimental treatment for multiple sclerosis performed better in a late-stage clinical trial than a commonly used therapy for the most prevalent form of the condition... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Re: Roche drug shows promise for less common form of MS

Postby CureOrBust » Thu Oct 08, 2015 11:48 pm

MSUK wrote:Swiss drugmaker Roche has said its experimental treatment for multiple sclerosis performed better in a late-stage clinical trial than a commonly used therapy for the most prevalent form of the condition... Read More - http://www.ms-uk.org/MSnews
...Roche compared ocrelizumab with a placebo...
:lol: So a "Placebo" is the therapy for PPMS. Ya gotta laugh at the truth.
User avatar
CureOrBust
Family Elder
 
Posts: 3348
Joined: Wed Jul 27, 2005 2:00 pm
Location: Sydney, Australia

Re: Roche drug shows promise for less common form of MS

Postby EricDrake » Fri Oct 09, 2015 1:18 pm

CureOrBust wrote:
MSUK wrote:Swiss drugmaker Roche has said its experimental treatment for multiple sclerosis performed better in a late-stage clinical trial than a commonly used therapy for the most prevalent form of the condition... Read More - http://www.ms-uk.org/MSnews
...Roche compared ocrelizumab with a placebo...
:lol: So a "Placebo" is the therapy for PPMS. Ya gotta laugh at the truth.


performed better in a late-stage clinical trial than a commonly used therapy for the most prevalent form of the condition

This part is related to the RRMS trial and they are talking abouth interferon-beta
EricDrake
Family Member
 
Posts: 41
Joined: Sun May 10, 2015 3:04 am

Re: Roche drug shows promise for less common form of MS

Postby MSbro » Sat Oct 10, 2015 5:55 am

This part is related to the RRMS trial and they are talking abouth interferon-beta


It's interesting that many of these new MAB drugs are compared in trials to the much older interferon type drugs and found to be "better". But for years there have been a number of articles that state these older drugs (CRABs) don't do much if anything for MS in the long run. So why test against something that really isn't much good for MS in the first place? I guess it's called slick marketing.
MSbro
Family Member
 
Posts: 61
Joined: Sun Apr 26, 2015 4:32 am


Return to Ocrevus (Ocrelizumab)

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service